- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00687037
Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power
February 12, 2009 updated by: Sanofi
Uni Centric Study, Phase III, for Safety Oral Mucosa Evaluation: Basic Acceptability With Odontological Follow up - Cepacol Canela Power
To prove the safety, in normal conditions, of the odontological use formulation of the product Cepacol Canela Power.
Study Overview
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
São Paulo, Brazil
- Sanofi-Aventis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Integral buccal mucous (without oral pathologies);
- Normal odontological exams;
Exclusion Criteria:
- Lactation or gestational risk or gestation;
- Use of Anti-inflammatory or immunosuppression drugs 15 days before the study;
- Being in odontological treatment;
- Pathological or mucous disease which can interfere or active gynaecological disease which may interfere wtih study results;
- Personal history of allergic disease in the area to be treated;
- Allergic or atopic history;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: I
Cetylpyridinium chloride during 21 days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Patients will be evaluated according to the adverse reactions and the intensity of them. The volunteers will also answer a questionnaire about the physical attributes of the product.
Time Frame: 21 days
|
21 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (Actual)
February 1, 2008
Study Registration Dates
First Submitted
May 27, 2008
First Submitted That Met QC Criteria
May 29, 2008
First Posted (Estimate)
May 30, 2008
Study Record Updates
Last Update Posted (Estimate)
February 13, 2009
Last Update Submitted That Met QC Criteria
February 12, 2009
Last Verified
February 1, 2009
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPYRY_L_03930
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Cetylpyridinium chloride
-
Peking University People's HospitalCompletedGingivitis | Pharyngitis AcuteChina
-
Rosa TarragoDentaid SLCompletedCOVID-19 | SARS-CoV-2 InfectionSpain
-
University of Illinois at ChicagoCompletedWound Heal | Oral MicrobiomeUnited States
-
University of Toledo Health Science CampusProMedica Health System; The University of Toledo; ARMS Pharmaceutical LLC; Pediatric...WithdrawnViral Upper Respiratory Tract InfectionUnited States
-
Aziende Chimiche Riunite Angelini Francesco S.p.ACross Research S.A.Completed
-
Seoul National University HospitalCompletedSarcopeniaKorea, Republic of
-
Seoul National University HospitalCompleted
-
Procter and GambleCompletedGingivitisUnited States, Guatemala
-
SanofiCompleted
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates FoundationCompletedPeriodontitis | Premature Birth of NewbornNepal